EyePoint Pharmaceuticals
EYPT
EYPT
36 hedge funds and large institutions have $176M invested in EyePoint Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 10
11% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 9
Holders
36
Holding in Top 10
1
Calls
$634K
Puts
$520K
Top Buyers
| 1 | +$58.7M | |
| 2 | +$661K | |
| 3 | +$196K | |
| 4 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$189K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$169K |
Top Sellers
| 1 | -$1.43M | |
| 2 | -$829K | |
| 3 | -$357K | |
| 4 |
Renaissance Technologies
New York
|
-$290K |
| 5 |
Creative Planning
Overland Park,
Kansas
|
-$162K |